Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned an average rating of “Hold” from the eleven research firms that are presently covering the company ...

StockNews.com started coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a report issued on Tuesday ...

Scott Braunstein, Chairman and CEO of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), recently executed several stock transactions, according to a filing with the Securities and Exchange Commission.

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MARINUS PHARMACEUTICALS ($MRNS) is expected to release its quarterly earnings data on Tuesday, March 11th after market close, per Finnhub. Analysts are expecting ...

Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...

Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...

For the pharmaceutical company, literacy is needed in specialized and core job skills, including research, supply chain, and finance. Then there's fluency in AI technology. "There are so many ways ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has blacklisted Aveo Pharmaceuticals Pvt Limited, an India-based company implicated in the illegal production and ...